Xanomeline/trospium chloride
A combination medication for the treatment of schizophrenia and Alzheimer's disease
Xanomeline/trospium chloride is a combination medication used in the treatment of schizophrenia and Alzheimer's disease. It consists of two active ingredients: xanomeline, a muscarinic receptor agonist, and trospium chloride, a muscarinic receptor antagonist. This combination is designed to enhance therapeutic effects while minimizing side effects associated with muscarinic receptor activation.
Pharmacology
Xanomeline
Xanomeline is a selective agonist for the muscarinic acetylcholine receptors, particularly the M1 and M4 subtypes. These receptors are involved in cognitive processes and are found in high concentrations in the central nervous system. Xanomeline's action on these receptors is believed to improve cognitive function and reduce psychotic symptoms in patients with schizophrenia and Alzheimer's disease.
Trospium Chloride
Trospium chloride is a muscarinic receptor antagonist that primarily acts on peripheral muscarinic receptors. It is used to counteract the peripheral side effects of xanomeline, such as gastrointestinal disturbances and excessive salivation, by blocking the action of acetylcholine on these receptors. This allows xanomeline to exert its central effects without causing significant peripheral side effects.
Mechanism of Action
The combination of xanomeline and trospium chloride works by selectively targeting the central muscarinic receptors while minimizing peripheral activation. Xanomeline activates the M1 and M4 receptors in the brain, which are associated with improved cognitive function and reduced psychotic symptoms. Trospium chloride, on the other hand, blocks the muscarinic receptors in the peripheral nervous system, reducing unwanted side effects such as nausea and diarrhea.
Clinical Use
Xanomeline/trospium chloride is primarily used in the treatment of schizophrenia and Alzheimer's disease. In schizophrenia, it helps in reducing symptoms such as hallucinations, delusions, and cognitive impairments. In Alzheimer's disease, it aims to improve cognitive function and slow the progression of symptoms.
Side Effects
The combination of xanomeline and trospium chloride is generally well-tolerated. Common side effects may include dry mouth, constipation, and urinary retention, which are primarily due to the action of trospium chloride. The central effects of xanomeline may include dizziness and headache.
Related Pages
Ad. Transform your life with W8MD's
GLP-1 weight loss injections special from $29.99 with insurance
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
